The Asco Post

Today in Oncology

Current News from the World of Oncology Last Updated: Tuesday, May 05, 2015 11:02:14 PM

Featured Columnists

Heal Thy Patient … Reflections on the Human Side of Medicine Chandrakanth Are, MBBS, FRCS, FACS  

Clinical Trial Participation: ‘Is It All Worth It?’ Lee M. Krug, MD  

Health-Care Fraud and Abuse: Implications for Oncology Z. Kevin Lu, PhD, Brian Chen, JD, PhD, Zaina Qureshi, PhD, MPH, Oliver Sartor, MD, and Charles Bennett, MD, PhD, MPP  

More Featured Columnists

Expert Opinions

Opioid-Reduction Strategy for Postoperative Pain After Breast Cancer Surgery Patrick I. Borgen, MD  

In Search of ‘Just’ Prices: Questioning the High Cost of New Cancer Drugs Hagop M. Kantarjian, MD  

20 Years of NCCN: The Best Is Yet to Come Robert W. Carlson, MD  

More Expert Opinions

Meeting News

20 Years of NCCN: The Best Is Yet to Come Remembering Dr. Jane Weeks’ Pioneering Work and NCCN’s Outcomes Research I... No Survival Benefit From Adjuvant Sorafenib or Sunitinib in Kidney Cancer Should Oncologists Be Ordering Breast Cancer Gene Panels? More Meeting News

Journal Spotlight

Radiotherapy or Not in Older Women Receiving Breast-Conserving Surgery and... Analysis Shows No Link Between Aromatase Inhibitor-Related Musculoskeletal... Evidence of Recurrence-Free, Disease-Free, and Overall Survival Benefit of... Immune Gene Profile Strongly Associated With Benefit of Adjuvant Trastuzum... More Journal Spotlights

Health-Care Policy

Health-Care Fraud and Abuse: Implications for Oncology Ongoing Controversies in Allocating Our Health‑Care Resources New Oncology Care Model: Encouraging Better Coordination for Cancer Care Medicine Turned Upside Down More Health-care Policy

Drugs & Regimens

Evidence of Recurrence-Free, Disease-Free, and Overall Survival Benefit of Aspirin and COX‑2 Inhibitor Use in Stage III Colon Cancer Radiotherapy or Not in Older Women Receiving Breast-Conserving Surgery and Endocrine Treatment? Analysis Shows No Link Between Aromatase Inhibitor–Related Musculoskeletal/Vasomotor Symptoms and Relapse-Free Survival No Survival Benefit From Adjuvant Sorafenib or Sunitinib in Kidney Cancer More Drugs & Regimens

Oncology Worldwide

Noncommunicable Diseases Are the Leading Cause of Death in Low- and Middle-Income Countries How the International Innovation Grant Is Improving Cancer Care for Women in Myanmar Global Oncology Launches Global Cancer Project Map With NCI Addressing the Global Cancer Burden More Oncology Worldwide

Patient's Corner

Too Young to Have Cancer I Refuse to Capitulate to Cancer Having Cancer So Early in Life Gave Me Purpose Cancer Was My Wake-Up Call to a Healthier Life More Patient's Corner
/
More on Twitter